![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 32, 24857-24864, August 11, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶,
¶
,
, and
§
**
From the
Cardiovascular Research Program, Research Institute,
Hospital for Sick Children and Departments of § Biochemistry and of
Laboratory Medicine and Pathobiology, University of Toronto,
Ontario, Canada M5G 1X8
Received for publication, April 2, 2000, and in revised form, May 15, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Synthesis of aortic elastin peaks in the
perinatal period and then is strongly down-regulated with postnatal
development and growth. Decreased stability of elastin mRNA
contributes to this developmental decrease in chick aortic elastin
production. We have previously shown that destabilization of elastin
mRNA is correlated with decreased binding of cytosolic protein(s)
to a large, GC-rich region of secondary structure in the
3'-untranslated region (3'-UTR) of elastin mRNA. In this study,
using gel migration shift assays, deletion constructs, and antisense
competition assays, we identify a major protein-binding site in
the 3'-UTR of elastin as a GA-rich sequence (UGGGGGGAGGGAGGGAGGGA),
which we have designated the G3A motif. This motif is present in the
3'-UTR of elastin from several species. Binding proteins are present in
both nuclear and cytoplasmic extracts, and their abundance is
associated with tissues producing elastin and correlated with
circumstances in which elastin mRNA is stable. These results
suggest that the conserved GA-rich sequence of the elastin 3'-UTR is an
important element in the regulation of stability of the elastin mRNA.
Elastin is the major connective tissue protein of large arteries
such as the aorta, providing these tissues with the properties of
extensibility and elastic recoil. Together with collagen, elastin is
essential for the structural integrity and physiological function of
the arterial blood vessels. Synthesis and accumulation of elastin in
the aorta takes place over a relatively short period of time during
development and growth, and is essentially complete by early adult life
(1, 2). For example, production of elastin in the aorta of the chicken
is very rapid around the time of hatching but decreases markedly by 4 weeks and can no longer be detected after 10-12 weeks of age (3). This
developmental decrease in elastin synthesis is reflected in a marked
reduction in steady-state levels of mRNA for elastin (3, 4).
We have previously shown that decreased stability plays a role in the
developmental decline in steady-state levels of elastin mRNA (5).
For example, in the 2-day-old chicken, a period at which elastin
synthesis is rapid and elastin mRNA is abundant, the half-life of
aortic elastin mRNA is approximately 25 h. In contrast, by 8 weeks after hatching when elastin synthesis and steady-state mRNA
levels for elastin have fallen to low levels, the half-life of this
mRNA has decreased to approximately 7 h. Decreased stability
of elastin mRNA has also been reported to be important in
developmental regulation of elastin synthesis in rat lung (6), and
alterations in elastin mRNA stability have been suggested in at
least one form of cutis laxa, a connective tissue disease manifested by
defective elastic fiber formation (7). Recently, protein binding to a
sequence element in exon 30 of the coding region of elastin has been
reported to be important for destabilization of elastin mRNA in
adult rat lung fibroblasts, and it has been suggested that increased
elastin production induced by treatment of cells with transforming
growth factor In recent years the regulation of mRNA stability has emerged as an
important mechanism for controlling gene expression. It is now clear
that the stability of different mRNAs can vary greatly in
eukaryotes, with half-lives ranging from a few minutes to days. The
decay rates of many eukaryotic mRNAs have been shown to be regulated by a variety of developmental or environmental stimuli such
as hypoxia (9), hormones (10), and cytokines (11). Most of the
mechanisms that control mRNA stability share common features,
including specific interactions between trans-acting factors
and cis-acting elements in the mRNA (12). These
interactions serve to modulate the susceptibility of the mRNA to
degradation. Such cis-acting elements might be actual
ribonuclease target sites or sites that facilitate or hinder
ribonuclease attack elsewhere in the mRNA. Although such
cis elements could be present anywhere in the mRNA, many
of these sequences are situated in the 3'-untranslated region
(3'-UTR).1 In addition, two
common structural elements, the 5'-cap structure and the 3'-poly(A)
tail, also appear to have important roles in protecting the mRNA
from degradation by ribonucleases.
Although it is now clear that destabilization of mRNA plays a role
in the down-regulation of aortic elastin synthesis during development
and growth (5, 8), the precise molecular mechanisms contributing to the
control of elastin mRNA stability remain to be defined. Previous
evidence from our laboratory indicated that cytosolic proteins binding
to a large region of stable secondary structure in the 3'-UTR of
elastin was associated with the stabilization/destabilization of
elastin mRNA. Here, using deletion and competition analyses, we map
this cis-acting sequence to an approximately 20-nucleotide (nt) purine-rich sequence within this region of secondary structure. This sequence is conserved in the 3'-UTRs of elastins of several species. Furthermore, trans-acting proteins binding to this
sequence, apparently present in both cytosolic and nuclear fractions,
are enriched in tissues in which elastin is synthesized and are
particularly abundant at developmental periods when elastin mRNA is stable.
Synthesis of Full-length 3'-UTR and Deletion Constructs--
The
cDNA containing the full-length 3'-UTR of elastin was produced by
polymerase chain reaction (PCR) synthesis using primers corresponding
to the 5'- and 3'-ends of the 3'-UTR. The upper primer contained a 5'
HindIII and the lower primer contained a 3' XbaI
site for subsequent cloning into a pGEM-4Z vector (Promega). PCR
solutions included 1× PCR buffer (Qiagen), 5% Me2SO, 0.2 mM of each dNTPs, 1.0 mM MgCl2, 0.5 µM of both upper and lower primers, 1.25 units of
Taq polymerase (Qiagen), and either 0.5 µg of genomic DNA
or 12.5 ng of pTE2, a cDNA containing the full-length 3'-UTR of
chicken elastin mRNA (a gift from Dr. Shingo Tajima, National Defense Medical College, Japan), as template. Each PCR reaction was
denatured for 4 min at 94 °C, followed by PCR amplification using a
Robocycler 480 (Stratagene) (denaturation, 1 min at 95 °C;
annealing, 1 min between 51 °C and 65 °C; extension, 1 min at
72 °C). The full-length elastin 3'-UTR insert was cloned into the
pGEM-4Z vector and sequenced.
Deletions of various domains in the elastin 3'-UTR were made using a
PCR approach (13) with either chicken heart genomic DNA or pTE2 as the
primary template. One PCR reaction used an upper primer containing a 5'
HindIII site, as described above, and a lower primer
corresponding to approximately 18 bases of sequence upstream of the
deleted sequence together with approximately 18 bases downstream of the
deleted sequence. A second PCR reaction used a lower primer containing
a 3' XbaI site as described above, and an upper primer
corresponding to approximately 18 bases of sequence upstream of the
deleted sequence together with approximately 18 bases downstream of the
deleted sequence. The DNA fragments generated in this way were purified
using a QiaEx II gel extraction kit (Qiagen), mixed in a 1:1 molar
ratio and used as a template for primer extension and subsequent PCR
amplification using the HindIII upper primer and the
XbaI lower primer. This PCR step generated the full-length
construct incorporating the desired deletion in the 3'-UTR of elastin,
which was subsequently cloned into pGEM-4Z and sequenced. PCR
conditions were as described above.
All oligodeoxynucleotides were synthesized at the Center for Applied
Genomics, Hospital for Sick Children, Toronto, Canada. Primer
sequences used were as follows: Upper HindIII,
CGGAAGCTTCCGCCCACCATCACCGAT; lower XbaI,
GCCTCTAGACCATTAAAAACTTGTCCT; domain B deletion (5'-fragment, lower),
GGGGTCCCTGCCGGGAGCTTGGTGGGGATTTACATT; domain B deletion (3'-fragment,
upper), AATGTAAATCCCCACCAAGCTCCCGGCAGGGACCCC; domain D deletion
(5'-fragment, lower), CACCGGGGACCCTTCTTTACCCCTGAGTGCCCCGCG; domain D
deletion (3'-fragment, upper), CGCGGGGCACTCAGGGGTAAAGAAGGGTCCCCGGTG; domain E deletion (5'-fragment, lower),
CAAAGTGAGTAACATGAACCCGGGGCCGGCAGTGTC; domain E deletion (3'-fragment,
upper), GACACTGCCGGCCCCGGGTTCATGTTACTCACTTTG; region 3 deletion
(5'-fragment, lower), TCCCCCGCCACCGGGACCCCCTCGTGCTCAGCCCGGC; region 3 deletion (3'-fragment, upper), GCCGGGCTGAGCACGAGGGGGTCCCGGTGGCGGGGGA; region 4 deletion (5'-fragment, lower),
CAAAGTGAGTAACATGAAGTTCTTTCCTTCCCTGCGT; and region 4 deletion
(3'-fragment, upper), ACGCAGGGAAGGAAAGAACTTCATGTTACTCACTTTG.
A construct containing the elastin 3'-UTR, but lacking the sequence
from domains B through E ( Synthesis of Constructs Containing Region 4 and Region 5 in the
Elastin 3'-UTR--
Constructs containing sequence from either region
4 or region 5 of the elastin 3'-UTR were prepared by cloning a double
stranded oligodeoxynucleotide into the multiple cloning region of the
pGEM-4Z vector. The sense strand sequence of the
oligodeoxynucleotide used to synthesize the region 4 construct was
GGGTCCCCGGTGGCGGGACACTGCGGGGACACTGCCGGCCCCGGGTCCCCCCGGCCCC, with
additional 5' EcoRI and 3' HindIII sites. The
sense strand sequence of the oligodeoxynucleotide used to synthesize
the region 5 construct was TGGGGGGAGGGAGGGAGGGACGGAGGGAAGGAAAGAAGGGGT,
with additional 5' XbaI and 3' HindIII
sites. To prepare double stranded oligodeoxynucleotides, the sense and
antisense strands were heated to 100 min for 5-10 min and then cooled
rapidly on ice.
Preparation of in Vitro Transcripts--
An in vitro
transcription system (Promega) was used to produce RNA transcripts
(riboprobes) from 1 µg of linearized plasmid DNA. Plasmids containing
full-length elastin 3'-UTR cDNA and its deletion constructs were
linearized using XbaI, with the exception of the Preparation of Tissue Extracts--
Crude tissue extracts were
prepared by Dounce homogenization of tissues (20-30 strokes) in 2 ml
of ice-cold hypotonic buffer (25 mM Tris-HCl, pH 8, 0.5 mM EDTA). Homogenates were centrifuged at 10,000 × g for 20 min at 4 °C. The resulting supernatants were removed and quickly frozen at
A standard protocol was used for preparation of nuclear and cytoplasmic
extracts (14). Briefly, aortic tissues were homogenized in hypotonic
buffer containing 10 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 1 µg/ml leupeptin
(Sigma-Aldrich), 1 µg/ml aprotinin (Sigma-Aldrich), and 0.5 mM dithiothreitol (DTT). After centrifugation of the
homogenate for 15 min at 4 °C at 3300 × g, the
nuclei-containing pellet was separated from the supernatant containing
the cytoplasmic fraction and resuspended in low salt buffer (20 mM HEPES, pH 7.9, 25% glycerol, 1.5 mM
MgCl2, 0.02 M KCl, 0.2 mM EDTA, and
1 µg/ml each of leupeptin and aprotinin). Gentle addition of a high
salt buffer (same components as the low salt buffer except the
replacement of 0.02 M KCl with 1.2 M KCl)
released soluble proteins from the nuclei. Insoluble material was
removed by centrifugation at 25,000 × g for 30 min,
and the supernatant containing soluble nuclear proteins was dialyzed
into a moderate salt solution (20 mM HEPES, pH 7.9, 20%
glycerol, 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, and 1 µg/ml each of leupeptin and aprotinin). For
the preparation of cytoplasmic fractions, the supernatant obtained
after the initial centrifugation of the tissue homogenate was mixed
with 0.11 volume of 10× cytoplasmic buffer (0.3 mM HEPES,
pH 7.9, 1.4 M KCl, and 0.03 M
MgCl2) and centrifuged at 100,000 × g for
1 h. The resulting supernatant containing the cytoplasmic fraction
was dialyzed against the moderate salt solution described above.
Cytoplasmic and nuclear protein extracts were aliquoted and frozen at
Protein concentrations for all extracts were determined using the BCA
protein assay reagent (Pierce) using bovine serum albumin as a
standard. For cross-species analyses, tissues used for crude protein
extracts were either freshly isolated or previously frozen in liquid nitrogen.
Aortic Organ Culture--
Aortic tissue from 2-day-old chickens
was dissected and incubated in organ culture for 16 h. Conditions
of organ culture have been described previously (15). After incubation,
the aortic tissues were rinsed in phosphate-buffered saline and protein
extracts were prepared as described above.
RNA Mobility Shift Assays--
Protein extracts were incubated
at 20 °C for 30 min with 2-4 × 104 cpm of
32P-labeled transcripts in 5 mM HEPES buffer,
pH 7.9, containing 0.5-1 mM MgCl2, 7.5 mM KCl, 0.5 mM DTT, 0.12 mM EDTA,
and 200 ng/µl yeast tRNA (Sigma-Aldrich) in a total volume of 20 µl. The binding reaction mixture was then incubated with a 1:150 to
1:200 dilution of RNase Plus (0.83-1.25 units/ml RNase T1,
0.005-0.007 units/ml RNase A, 5 Prime Competitive RNA Gel Shift Assays--
All oligodeoxynucleotides
were synthesized by the Center for Applied Genomics, Hospital for Sick
Children, Toronto, Canada. For competition experiments with antisense
oligodeoxynucleotides, radiolabeled riboprobe was mixed with the
indicated amounts of antisense oligodeoxynucleotides, incubated at
70 °C for 10 min and left to cool to room temperature for at least
15 min before the addition of protein extracts. For competition
experiments with unlabeled sense riboprobes containing either region 4 (RP4) or region 5 (RP5) of the elastin 3'-UTR, protein extracts were first incubated with the indicated amounts of unlabeled competitors for
15 min at room temperature. Radiolabeled riboprobes were then added to
the reaction mixtures for another 15 min of incubation at room
temperature. All binding reaction mixtures were then subjected to RNase
digestion and polyacrylamide gel electrophoresis as described above.
Sequences of competitive antisense oligodeoxynucleotides (asODNs) used
were as follows: asODN3a (17 nt), CCCCTGAGTGCCCCTCG; asODN3b (18 nt),
CCTCCCTCCCTCCCCCCA; asODN3c (19 nt), TTCTTTCCTTCCCTGCGTC.
UV Cross-linking Assays--
RNA-protein binding reactions were
carried out as described above for mobility shift assays. After
ribonuclease digestion, the protein-RNA complexes were put on ice and
UV-irradiated for 10 min in a UV-Stratalinker apparatus (Stratagene).
Samples were then boiled in SDS sample buffer for 5 min and separated
by electrophoresis on 10% SDS-polyacrylamide gels. The gels were
subsequently dried under vacuum at 80 °C for 1 h and exposed to
the PhosphorImager screen (Molecular Dynamics).
Northern Blotting of RNA-Protein Complexes--
RNA gel shift
analyses were performed as described above but in the presence of
50-100 ng of non-radiolabeled riboprobes and 8-10 µg of protein
extracts. After RNase digestion and subsequent electrophoresis on 7%
native polyacrylamide gels, the RNA-protein complexes on the gel were
transferred to a HyBond N membrane (Amersham Pharmacia Biotech) by
electroblotting (10 V for the first hour, 25 V for the following 2 h in 0.3× TBE transfer buffer). RNA was cross-linked to the membranes
using a UV-Stratalinker (Stratagene). The blot was prehybridized for at
least 1 h at 42 °C with 50% formamide, 5× Denhardt's
solution, 5× saline/sodium phosphate/EDTA (SSPE), 0.1% SDS, and 100 µg/ml salmon sperm DNA, then hybridized for 16-18 h at 42 °C
using oligodeoxynucleotide probes radiolabeled with
[32P]dATP by end labeling. Blots were washed with 2×
SSPE, 0.1% SDS for 30-45 min at 55 °C, followed by 0.1× SSPE,
0.1% SDS for 15-20 min at 55 °C and exposed to x-ray film (Eastman
Kodak) at
Sequences of asODN3a, asODN3b, and asODN3c are given above. The
sequences of asODN2 and asODN3 were: asODN2,
CCCCGCAAGGAGCGATCAGACCAAGGGGGACGGCTGCTCCCCGCAGTTTATTCCGCGC; asODN3, TTCTTTCCTTCCCTCCGTCCCTCCCTCCCTCCCCCCACCCCTGAGTGCCCCGCG.
Sequence comparisons of the 3'-UTRs of chicken, rat, human, and
bovine elastins are shown in Fig.
1A. Chicken elastin has the
shortest of these UTRs, with a total of 491 nucleotides from the first
nucleotide beyond the stop codon to the polyadenylation signal
(4), compared with the longer bovine (965 nt) (16), human (1181 nt)
(17), and rat (1168 nt) (18) untranslated sequences. The chicken
elastin 3'-UTR contains two polyadenylation signals, although the first
of these does not appear to be used. All of these 3'-UTRs are notably
GC-rich, with the chicken elastin sequence containing ~70% GC
nucleotides. The region of stable secondary structure in the chicken
3'-UTR reported previously by us to be required for cytosolic protein
binding (4) is indicated in Fig. 1A.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
may be mediated through this mechanism
(8).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
B-E), was prepared as described previously (4).
B-E
construct, which was linearized using EcoRI. RNAs were
transcribed using T7 RNA polymerase. Plasmids containing either region
4 or region 5 of the elastin 3'-UTR were linearized with
HindIII, and RNA was transcribed using Sp6 RNA polymerase. For the synthesis of radioactively labeled probes, the reactions were
carried out at 37 °C for 1 h in the presence of
[
-32P]CTP or -GTP (3000 Ci/mmol), nucleotides,
RNase inhibitor, and buffer mixture as recommended by the manufacturer.
1 unit of RNase-free DNase was added to the reaction mixture for 15 min
at 37 °C to remove template DNA. After phenol/chloroform extraction,
the transcripts were precipitated using 2.4 M ammonium
acetate and ice-cold 100% ethanol for 1.5 h at
70 °C. The
RNA pellets were resuspended in 30 µl of RNase-free
10mM Tris-Hcl, 1 mM EDTA buffer (pH 8.0) and
purified on an RNase-free G-25 RNA purification column (Roche Molecular
Biochemicals). Determination of percentage incorporation of
radiolabeled nucleotides into transcripts was done by trichloroacetic acid precipitation. The integrity of the RNA was confirmed by 6%
native polyacrylamide gel electrophoresis. Unlabeled RNA transcripts were generated in a similar manner, except that the
[
-32P]CTP or -GTP was replaced with 0.5 mM
CTP or GTP.
70 °C.
80 °C until use.
3 Prime, Inc., Boulder, CO)
for a further 10-15 min at 37 °C. Electrophoresis of RNA-protein
complexes was carried out on 6% or 7% native polyacrylamide gels
(acrylamide/bisacrylamide ratio = 30/1) with 0.3× TBE (Tris
borate-EDTA) running buffer, pH 8.4. The gels were subsequently dried
under vacuum at 80 °C for 1 h and exposed to x-ray film at
70 °C or to the PhosphorImager screen (Molecular Dynamics).
70 °C or to a PhosphorImager screen (Molecular Dynamics).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (64K):
[in a new window]
Fig. 1.
A, sequence comparison of the 3'
untranslated regions of chicken (4), rat (18), human (17), and bovine
(16) elastin mRNAs. The boxed areas indicate
regions of sequence conservation (Domains A-E).
Polyadenylation signals are in boldface. The region of
stable secondary structure previously reported in the 3'-UTR of chicken
elastin (4) is contained between the arrows. B, map of
positions of conserved domains and regions of sequence used for
determination of the site of protein binding in the 3'-UTR of chicken
elastin. The full-length riboprobe used in gel migration shift
experiments included the entire 3'-UTR from immediately downstream of
the stop codon to immediately upstream of the polyadenylation
signal.
Cross-species examination of elastin 3'-UTR sequences revealed several
regions of sequence similarity, which have been designated domains A through E in Fig. 1A. Making
the assumption that 3'-UTR protein-binding sequences important for
mRNA stability might be conserved across species, the effect of
deletion of these domains on the ability of riboprobes (Fig.
1B) to bind to cytosolic proteins extracted from 2-day-old
chicken aorta was investigated, concentrating particularly on domains
B, D, and E, because these were contained within the region of
secondary structure, which we had previously shown to be required for
cytosolic protein binding (4). Gel migration shift assays using
riboprobes made from these deletion constructs are shown in Fig.
2A. Deletions of domains B and
E had no effect on protein binding. In contrast, deletion of domain D
consistently decreased cytosolic protein binding. Deletion of domain A
also had no effect on the formation of RNA-protein complexes in these
assays (data not shown). The importance of domain D for protein binding
was supported by the fact that deletion of a larger region of the
3'-UTR, which included domain D, designated region 3 in Fig.
1B, also strongly diminished protein binding (Fig.
2B). In contrast, deletion of a region of the 3'-UTR not
containing domain D, designated region 4 in Fig.
1B, had no effect on protein binding (Fig.
2B).
|
Identification of domain D as the site of protein binding was further
confirmed by gel migration shift assays using a 42-nucleotide riboprobe
corresponding to region 5 in Fig. 1B. This riboprobe included the entire domain D as well as 12 additional nucleotides on
the 3'-side of domain D. Protein binding to this riboprobe was strong
with cytosolic extracts from aortic tissues of 2-day-old chickens but
significantly diminished with extracts from 15-week-old chicken aorta
(Fig. 3A, left
panel). This was consistent with data published previously from
our laboratory using full-length 3'-UTR riboprobes (4). Unlabeled RP5
effectively competed for this labeled riboprobe (RP5, Fig.
3A, right panel), but protein binding was not
diminished by competition with another riboprobe (RP4) corresponding to
a region of 3'-UTR not containing domain D. Differences in position of
the labeled band and the presence of double bands in some lanes are
related to the amounts of cytosolic protein used in the gel shift
assays, with the upper band predominating when increased amounts of
protein are used.
|
Mapping of sequences important for protein binding also utilized competition experiments in which antisense oligodeoxynucleotides were annealed to the radiolabeled riboprobe before the addition of protein extracts (19). For these experiments, three antisense oligodeoxynucleotides were made, spanning regions 3a, 3b, and 3c in the 3'-UTR (Fig. 1B). These were designated asODN3a, asODN3b, and asODN3c. Using a 1000-fold molar excess of these antisense oligonucleotides, effective inhibition of RNA-protein complex formation was seen only with asODN3b (Fig. 3B).
These data indicated that the major protein-binding site mapped to an approximately 20-nt purine-rich sequence (UGGGGGGAGGGAGGGAGGGA) corresponding to region 3b (Fig. 3C), and containing at least a 4-fold repeat of a GGGA motif. This region was therefore designated as the G3A site. Consistent with the GA-rich nature of the identified binding site, unlabeled poly(G) and poly(GA) RNA polymers could compete with the radioactively labeled elastin riboprobe for cytosolic protein binding in gel shift experiments, but neither poly(A) nor poly(C) RNA polymers were effective competitors (data not shown).
To characterize proteins binding to the G3A site, radioactively labeled
riboprobes were incubated with cytosolic extracts followed by UV
cross-linking. After RNase digestion, the resulting RNA-protein complex
was electrophoresed on SDS-polyacrylamide gels (Fig.
4). Using the 3'-UTR as a riboprobe,
major protein bands corresponding to molecular masses of
approximately 36 and 62 kDa could be detected. No protein bands were
seen when cytosolic extracts were incubated with a riboprobe (
B-E)
lacking the region of secondary structure in the 3'-UTR of elastin.
This was consistent with earlier results showing that protein binding
required the presence of this region of stable secondary structure (4). In addition, consistent with earlier gel migration shift data both
shown here (Fig. 3) and published previously (4), protein binding was
significantly stronger in cytosolic extracts from aortic tissue of
2-day-old chickens as compared with similar extracts from 15-week-old
animals. Furthermore, protein binding activity was stronger in nuclear
extracts as compared with cytosolic extracts (Fig. 4B),
although the patterns of protein bands in nuclear and cytosolic
extracts were essentially identical. Age differences in protein binding
activity similar to those seen in cytosolic extracts were also observed
for nuclear extracts (data not shown).
|
A novel Northern blotting strategy involving probing of the RNA-protein
complex with radiolabeled antisense ODNs was also used to confirm the
G3A sequence as the binding site. Conventional RNA gel shift assays
were carried out using non-radiolabeled riboprobes and cytosolic
extracts from 2-day-old and 15-week-old chicken aortas. After RNase
digestion and electrophoresis on native gels, the RNA-protein complexes
were transferred to nylon membranes and subsequently probed with
radioactively labeled antisense ODNs. Results of these experiments are
shown in Fig. 5A. A single
band was detected using either asODN3 or asODN3b as radiolabeled probes to hybridize to the protein-protected, RNase-resistant region. No
signal was detected when asODN2, asODN3a, or asODN4 (data not shown)
were used as radiolabeled probes for Northern blotting. A faint band
corresponding to the RNA-protein complex was detected using asODN3c
after longer exposure time.
|
Gel migration shift data (Fig. 3), UV cross-linking data (Fig. 4), and previous reports from our laboratory (4) had shown that the RNA-protein complex detected in gel shift assays was more prominent in cytosolic extracts from aortic tissue of 2-day-old chicken, when elastin mRNA is stable, as compared with similar extracts from 15-week-old chicken in which elastin mRNA is relatively unstable. Consistent with these results, the RNA-protein complex detected using a radiolabeled asODN3b probe was also more prominent in aortic extracts from 2-day-old as compared with 15-week-old chickens (Fig. 5A). Furthermore, the RNA-protein complex detected with asODN3b was also more prominent in extracts of fresh aortic tissue from 2-day-old chickens as compared with similar tissue, which had been subjected to organ culture for 16 h (Fig. 5B). This result was consistent with earlier evidence from our laboratory for destabilization of elastin mRNA during organ culture (5). In the absence of unlabeled riboprobe, no band could be detected with radiolabeled asODN3b, indicating that this labeled antisense oligodeoxynucleotide was not binding directly to the cytosolic protein. Furthermore, preincubation of the cytosolic extract with proteinase K before incubation with the unlabeled riboprobe abolished detection of RNA-protein complexes with asODN3b (Fig. 5B). Although the protein or proteins binding to the G3A sequence was present in cytosolic extracts of aortic tissues, consistent with earlier data (Fig. 4) a comparison of nuclear and cytosolic extracts demonstrated that this protein was clearly enriched in nuclear extracts (Fig. 5C).
Sequences corresponding to the G3A sequence, identified as the major
protein-binding site in the 3'-UTR of chicken elastin mRNA, are
conserved in the 3'-UTRs of human, bovine, and rat elastin mRNAs
(Fig. 3C). Such cross-species sequence conservation is
consistent with a biological significance for this
cis-acting sequence. Because of the occurrence of G3A-like
sequences in 3'-UTRs of other elastin mRNAs, the tissue and species
specificities of the G3A binding site were assessed. Because protein
binding could be detected in both cytosolic and nuclear fractions, for
convenience these experiments utilized total tissue extracts of various
tissues from 2-day-old chickens and 9-day-old neonatal rats and from
100-day-old fetal sheep aorta. A riboprobe corresponding to the
full-length 3'-UTR of chicken elastin mRNA was used in these gel
shift experiments (Fig. 6A).
Prominent binding to the chick sequence was seen with extracts of
chicken aortic and lung tissue, with weaker binding to extracts of
heart and skin, and very little binding to extracts of liver
tissue. Similarly, significant binding was seen to extracts of aortic
and lung tissues from rat and aortic tissue from fetal sheep. In
contrast, extracts of rat liver tissue showed little or no binding
activity.
|
To confirm that this binding was to the G3A site, these RNA-protein
complexes prepared using unlabeled riboprobes were transferred to nylon
membranes and probed with radioactively labeled asODN3b (Fig.
6B), as described for Fig. 5. Again, the RNA-protein complex detected in this way was prominent in extracts of aortic tissues from
all species examined and in lung tissues of chicken and rat. In
contrast, extracts of liver tissue from chicken and rat showed little
or no binding. These results demonstrated clearly that proteins binding
to the chicken G3A sequence were present in tissues of other species
and that these proteins were particularly prominent in tissues
producing elastin.
| |
DISCUSSION |
|---|
|
|
|---|
Earlier data from our laboratory demonstrated that one factor contributing to the decline in steady-state levels of elastin mRNA with postnatal development and growth of the chicken aorta was a progressive destabilization of elastin mRNA (5). These data showed that the half-life of the message decreased from about 25 h in the 2-day-old chicken when elastin mRNA and synthesis is abundant, to approximately 7 h in the 8-week-old chicken when elastin production and mRNA levels are in rapid decline. Subsequently, we identified a large GC-rich region of stable secondary structure in the 3'-UTR of elastin mRNA and correlated binding of cytosolic protein or proteins to this region with developmental stages when the elastin message was stable (4).
Here we have extended these investigations, mapping the site of binding of the developmentally regulated protein or proteins to a purine-rich sequence of approximately 20 nucleotides located within the region of secondary structure previously implicated in regulation of elastin message stability (4). This sequence (UGGGGGGAGGGAGGGAGGGA) has been designated as the G3A site. Data from deletion constructs, competition with antisense oligodeoxynucleotides, and competition with RNA nucleotides are all consistent with protein binding at the G3A site. Furthermore, this site has also been specifically identified by Northern blotting of RNA-protein complexes using short, radioactively labeled antisense probes.
The G3A site includes four tandem repeats of a GGGA sequence. Similar GGGA repeats are also present at approximately the same site in human, bovine, and rat elastin 3'-UTRs, and we have shown that tissue extracts from ovine aorta and rat aorta and lung tissues appear to bind to this chicken G3A sequence in gel shift experiments. Although only partial sequence is available for the 3'-UTR of ovine elastin mRNA, the G3A region of this 3'-UTR is identical to that of bovine elastin (20). Conservation of this G3A site, particularly between the more phylogenetically separated avian and mammalian species, and the particular presence of the binding protein or proteins in tissues actively producing elastin, suggest that there is a significant elastin-related biological role for this sequence. Although we would predict that this role is generally related to developmental regulation of elastin mRNA stability, at present such a correlation has been made only for chicken elastin.
Although the G3A sequence appears to be the major protein-binding site in the 3'-UTR associated with developmental regulation of elastin mRNA stability in chicken, other minor protein-binding sites may also be present. Indeed, the fact that deletion of domain D or region 3 did not totally abolish protein binding supports the presence of such accessory sites. Some affinity of the G3A binding protein for single GGGA motifs, seven of which occur outside domain D and region 3 (Fig. 1A), may account for the weak binding remaining after deletion of these regions. On the other hand, the presence of other proteins binding to non-G3A sites but with similar mobility on gel shift experiments cannot be totally ruled out.
The ability of short, radioactively labeled antisense oligonucleotide probes to hybridize specifically to RNase-protected RNA-protein complexes appears to be unusual and has not, to our knowledge, been previously reported. This hybridization was not the result of direct binding of antisense oligonucleotide probes to proteins, because no signal was apparent with cytosolic proteins alone. Nor was such binding the result of dissociation of the RNA from the complex during transfer to nylon membranes, because RNA-protein complexes UV cross-linked before transfer could still be detected in this way (data not shown). Whatever the mechanism, the specificity of the hybridization, despite the presence of protein, indicates that sufficient RNA nucleotide sequence must remain available to interact with the antisense probe.
The G3A site does not resemble other known cis-acting 3'-UTR
sequences affecting mRNA stability, including AU-rich elements of
c-myc or c-fos mRNAs (21),
iron-responsive elements of transferrin receptor mRNA (22), or the
C-rich element of
-globin mRNA (23). Although the G3A sequence
is well-conserved within elastin 3'-UTRs, few occurrences of this
sequence in 3'-UTRs of other messages could be identified by data base
searches. Although the sequence match is strong in human acid
phosphatase 5 (GGGGGAGGGAGGGAGGGA, GenBankTMaccession
number NM001611), this sequence is not as well-conserved at
similar sites in rat (GenBankTM accession number M76110),
mouse (GenBankTM accession number AV379526), or pig
(GenBankTM accession number M98553) acid phosphatase 5. Similarly, although the sequence match is strong in the 3'-UTR of human
preprocathepsin P (GGGGGAGGGAGGGAGGGA, GenBankTM accession
number AF009923), the sequence is not evident in the 3'-UTR of mouse
preprocathepsin P (GenBankTM accession number AF158182). No
reports of post-transcriptional regulation of human acid phosphatase 5 or preprocathepsin P could be found in the literature. A 3-fold tandem
GGGA repeat is also present in the 3'-UTR of mRNA coding for the
paraxis protein regulating somite formation in chicken
(GenBankTM accession number U76665). However, sequences of
mRNAs for this protein in other species were not available for comparison.
Our data indicate that the aortic G3A binding protein is enriched in nuclear as compared with cytoplasmic fractions, suggesting that interaction of protein with the G3A sequence may take place before transport of elastin mRNA from the nucleus to the cytoplasm. The presence of the protein in the cytosolic fraction may therefore be due to its carriage into the cytoplasm with the elastin mRNA. However, we cannot rule out the possibility that the protein is exclusively nuclear and that the detection of smaller amounts of binding protein in the cytosolic fraction may simply be accounted for by contamination from the nuclear fraction during the fractionation procedure.
At least three members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family of proteins, hnRNP A1 (24), hnRNP F (25), and hnRNP H' (DSEF-1) (26, 27), are known to bind to G-rich RNA sequences, including, in most cases, at least one GGGA motif. However, any relationship between the G3A binding protein and known G-binding hnRNPs remains speculative, because these hnRNPs have usually been implicated in regulation of message splicing or in pre-RNA cleavage and polyadenylation rather that mRNA stability (28).
Sequences containing a single GGGA motif have also been identified as particularly effective targets for antisense oligonucleotide-induced degradation of a variety of mRNAs by RNase H (29). The basis for the prevalence of a TCCC sequence in the most potent antisense oligonucleotides is not understood, although it has led to the suggestion that the GGGA motif may be a preferred site for RNase digestion (29). If this is the case, it is tempting to speculate that the presence of a tandemly repeated GGGA sequence in elastin mRNA may make this message particularly susceptible to RNase attack when the G3A site is not protected by protein binding. However, it is not clear how regulation of turnover of elastin mRNA could be related to a process thought to involve degradation of DNA-RNA hybrids by RNase H.
The data presented here provide further insights into the regulation of
elastin mRNA stability during aortic development and growth.
Although the evidence for the role of this cis-acting sequence is correlative, the phylogenetically conserved nature of the
G3A motif, the prevalence of the binding protein in tissues producing
elastin, and the correlation of levels of binding protein with
circumstances of stable elastin mRNA all suggest that this motif
plays an important role in determining turnover rates of the elastin
message. Although the mechanism by which interaction of proteins with
the G3A sequence might affect message stability remains a matter of
speculation, the fact that this sequence is located within a large
region of stable secondary structure in the 3'-UTR of the elastin
mRNA (4) suggests the possibility that RNA/protein interactions at
this site may alter the stability of this secondary structure, perhaps
affecting the accessibility of endogenous RNases to the mRNA.
However, detailed understanding of the mechanism of this process awaits
further characterization of the nature of binding protein and the
consequences of its interaction with the G3A motif in elastin mRNA.
| |
ACKNOWLEDGEMENT |
|---|
We acknowledge the technical assistance of E. Sitarz.
| |
FOOTNOTES |
|---|
* This work was supported by a grant from the Medical Research Council of Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Recipients of Studentship awards from the Medical Research Council of Canada.
** To whom correspondence should be addressed: Division of Cardiovascular Research, Hospital for Sick Children, 555 University Ave., Toronto, ON Canada, M5G 1X8. Tel.: 416-813-6704; Fax: 416-813-7480; E-mail: fwk@sickkids.on.ca.
Published, JBC Papers in Press, May 26, 2000, DOI 10.1074/jbc.M002776200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: UTR, untranslated region; nt, nucleotide(s); PCR, polymerase chain reaction; DTT, dithiothreitol; ODN, oligodeoxynucleotide; asODN, antisense oligodeoxynucleotide; hnRNP, heterogeneous nuclear ribonucleoprotein; SSPE, saline/sodium phosphate/EDTA; RP4 and RP5, riboprobes corresponding to regions 4 and 5.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Lefevre, M., and Rucker, R. B. (1980) Biochim. Biophys. Acta 630, 519-529 |
| 2. | Davis, E. C. (1993) Histochemistry 100, 17-26 |
| 3. | Keeley, F. W., Hussain, R. A., and Johnson, D. J. (1990) Arch. Biochem. Biophys. 282, 226-232 |
| 4. | Hew, Y., Grzelczak, Z., Lau, C., and Keeley, F. W. (1999) J. Biol. Chem. 274, 14415-14421 |
| 5. | Johnson, D. J., Robson, P., Hew, Y., and Keeley, F. W. (1995) Circ. Res. 77, 1107-1113 |
| 6. | Swee, M. H., Parks, W. C., and Pierce, R. A. (1995) J. Biol. Chem. 270, 14899-14906 |
| 7. | Zhang, M. C., He, L., Giro, M., Yong, S. L., Tiller, G. E., and Davidson, J. M. (1999) J. Biol. Chem. 274, 981-986 |
| 8. | Zhang, M., Pierce, R. A., Wachi, H., Mecham, R. P., and Parks, W. C. (1999) Mol. Cell. Biol. 19, 7314-7326 |
| 9. | Dibbens, J. A., Miller, D. L., Damert, A., Risau, W., Vadas, M. A., and Goodall, G. J. (1999) Mol. Biol. Cell 10, 907-919 |
| 10. | Dodson, R. E., and Shapiro, D. J. (1994) Mol. Cell. Biol. 14, 3130-3138 |
| 11. | Stoeckle, M. Y. (1992) Nucleic Acids Res. 20, 1123-1127 |
| 12. | Ross, J. (1995) Microbiol. Rev. 59, 423-450 |
| 13. | Innis, M. A., Gelfand, D. H., Sninsky, J. J., and White, T. J. (eds) (1990) PCR Protocols , pp. 177-183, Academic Press, San Diego |
| 14. | Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., and Smith, J. A. (eds) (1989) Current Protocols in Molecular Biology , pp. 12.1.1-12.1.9, John Wiley and Sons, New York |
| 15. | Johnson, D. J., and Keeley, F. W. (1990) Connect Tissue Res. 24, 277-288 |
| 16. | Raju, K., and Anwar, R. A. (1987) J. Biol. Chem. 262, 5755-5762 |
| 17. | Indik, Z., Yeh, H., Ornstein-Goldstein, N., Sheppard, P., Anderson, N., Rosenbloom, J. C., Peltonen, L., and Rosenbloom, J. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 5680-5684 |
| 18. | Pierce, R. A., Alatawi, A., Deak, S. B., and Boyd, C. D. (1992) Genomics 12, 651-658 |
| 19. | Fraboulet, S., Boudouresque, F., Delfino, C., and Ouafik, L. (1998) Endocrinology 139, 894-904 |
| 20. | Yoon, K., Davidson, J. M., Boyd, C., May, M., LuValle, P., Ornstein-Goldstein, N., Smith, J., Indik, Z., Ross, A., Golub, E., and Rosenbloom, J. (1985) Arch. Biochem. Biophys. 241, 684-691 |
| 21. | Vakalopoulou, E., Schaack, J., and Shenk, T. (1991) Mol. Cell. Biol. 11, 3355-3364 |
| 22. | Eisenstein, R. S., and Blemings, K. P. (1998) J. Nutr. 128, 2295-2298 |
| 23. | Weiss, I. M., and Liebhaber, S. A. (1995) Mol. Cell. Biol. 15, 2457-2465 |
| 24. | Burd, C. G., and Dreyfuss, G. (1994) EMBO J. 13, 1197-1204 |
| 25. | Matunis, M. J., Xing, J., and Dreyfuss, G. (1994) Nucleic Acids Res. 22, 1059-1067 |
| 26. | Bagga, P. S., Arhin, G. K., and Wilusz, J. (1998) Nucleic Acids Res. 26, 5343-5350 |
| 27. | Qian, Z., and Wilusz, J. (1994) Nucleic Acids Res. 22, 2334-2343 |
| 28. | Krecic, A. M., and Swanson, M. S. (1999) Curr. Opin. Cell Biol. 11, 363-371 |
| 29. | Tu, G., Cao, Q., Zhou, F., and Israel, Y. (1998) J. Biol. Chem. 273, 25125-25131 |
This article has been cited by other articles:
![]() |
S. Yang, M. A. Nugent, and M. P. Panchenko EGF antagonizes TGF-{beta}-induced tropoelastin expression in lung fibroblasts via stabilization of Smad corepressor TGIF Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L143 - L151. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mao, X. Pan, and L. Gu Evidence That a Mutation in the MLH1 3'-Untranslated Region Confers a Mutator Phenotype and Mismatch Repair Deficiency in Patients with Relapsed Leukemia J. Biol. Chem., February 8, 2008; 283(6): 3211 - 3216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deschenes-Furry, K. Mousavi, F. Bolognani, R. L. Neve, R. J. Parks, N. I. Perrone-Bizzozero, and B. J. Jasmin The RNA-Binding Protein HuD Binds Acetylcholinesterase mRNA in Neurons and Regulates its Expression after Axotomy J. Neurosci., January 17, 2007; 27(3): 665 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Akagawa, A. Tajima, Y. Sakamoto, B. Krischek, T. Yoneyama, H. Kasuya, H. Onda, T. Hori, M. Kubota, T. Machida, et al. A haplotype spanning two genes, ELN and LIMK1, decreases their transcripts and confers susceptibility to intracranial aneurysms Hum. Mol. Genet., May 15, 2006; 15(10): 1722 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mukudai, S. Kubota, T. Eguchi, S. Kondo, K. Nakao, and M. Takigawa Regulation of Chicken ccn2 Gene by Interaction between RNA cis-Element and Putative trans-Factor during Differentiation of Chondrocytes J. Biol. Chem., February 4, 2005; 280(5): 3166 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bunda, N. Kaviani, and A. Hinek Fluctuations of Intracellular Iron Modulate Elastin Production J. Biol. Chem., January 21, 2005; 280(3): 2341 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Marano, M. Brankov, and P. E. Rakoczy Discovery of a Novel Control Element within the 5'-Untranslated Region of the Vascular Endothelial Growth Factor: REGULATION OF EXPRESSION USING SENSE OLIGONUCLEOTIDES J. Biol. Chem., September 3, 2004; 279(36): 37808 - 37814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deschenes-Furry, G. Belanger, N. Perrone-Bizzozero, and B. J. Jasmin Post-transcriptional Regulation of Acetylcholinesterase mRNAs in Nerve Growth Factor-treated PC12 Cells by the RNA-binding Protein HuD J. Biol. Chem., February 14, 2003; 278(8): 5710 - 5717. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mazumder, V. Seshadri, H. Imataka, N. Sonenberg, and P. L. Fox Translational Silencing of Ceruloplasmin Requires the Essential Elements of mRNA Circularization: Poly(A) Tail, Poly(A)-Binding Protein, and Eukaryotic Translation Initiation Factor 4G Mol. Cell. Biol., October 1, 2001; 21(19): 6440 - 6449. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||